On February 16, the American Cancer Society National Consortium for Cancer Screening and Care (ACS National Consortium) released a set of consensus recommendations in a new report Responding to the COVID-19 Pandemic: Improving Cancer Screening and Care in the US. Companion materials are also available.
The ACS National Consortium launched in March 2021 with the aim to quicken the nation’s collective response to the COVID-19 pandemic’s detrimental impact on cancer screening and care. The group represents a diverse, multi-sector coalition of 28 organizational members including government agencies, leading cancer advocacy organizations, professional societies, research institutions, national roundtables, leading health organizations, and other relevant industry leaders and partners.
To develop the recommendations, the ACS National Consortium hosted public forums, informational webcasts, and member summits, and identified key opportunities where partners can catalyze change by accelerating, strengthening, and mobilizing around sensible, but bold, cancer screening and care activities. The report is geared towards clinicians, health systems, public health partners, and advocacy organizations.
More information can be found here at consortium.acs4ccc.org